SEP 11, 2026 · INTERVENTIONAL STUDY
Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
ClinicalTrials.gov
This is an active clinical trial registration with no posted results; it describes a planned interventional study in a critical population with mortality as primary endpoint, but outcome data are not yet available.
Reported
Planned enrollment192
Primary outcome measureMortality rate at 4 weeks
Secondary outcome measureMortality rate at 12 weeks